1. Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice. Issue 5 (29th October 2021) Authors: Tyson, Luke David; Cheng, Alexandra; Kelleher, Charles; Strathie, Kirstin; Lovendoski, James; Habtemariam, Zebib; Lewis, Heather Journal: European journal of gastroenterology & hepatology Issue: Volume 34:Issue 5(2022) Page Start: 567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder. (October 2020) Authors: Kim, Jin Un; Majid, Amir; Judge, Rebekah; Crook, Peter; Nathwani, Rooshi; Selvapatt, Nowlan; Lovendoski, James; Manousou, Pinelopi; Thursz, Mark; Dhar, Ameet; Lewis, Heather; Vergis, Nikhil; Lemoine, Maud Journal: Lancet gastroenterology and hepatology Issue: Volume 5:Number 10(2020) Page Start: 886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗